Survivin Is a Viable Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-11-2592
Full Text
Open PDFAbstract
Available in full text
Date
March 8, 2012
Authors
Publisher
American Association for Cancer Research (AACR)